Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor–Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202

PURPOSE: Adherence to aromatase inhibitor (AI) therapy for early-stage breast cancer is limited by AI-associated musculoskeletal symptoms (AIMSS). Duloxetine is US Food and Drug Administration approved for treatment of multiple chronic pain disorders. We hypothesized that treatment of AIMSS with dul...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Oncol
Main Authors: Henry, N. Lynn, Unger, Joseph M., Schott, Anne F., Fehrenbacher, Louis, Flynn, Patrick J., Prow, Debra M., Sharer, Carl W., Burton, Gary V., Kuzma, Charles S., Moseley, Anna, Lew, Danika L., Fisch, Michael J., Moinpour, Carol M., Hershman, Dawn L., Wade, James L.
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2018
Subjects:
ORIGINAL REPORTS
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5805479/
https://ncbi.nlm.nih.gov/pubmed/29136387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.74.6651
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items